IE 11 is a very old Browser and it`s not supported on this site

Consolidated statement of changes in equity

in CHF 1 000

 

Share capital

 

Treasury shares

 

Retained earnings

 

Total

Balances at January 1, 2021

 

11 080

 

(8 241)

 

3 884 708

 

3 887 547

Dividend

 

 

 

(199 440)

 

(199 440)

Trade with treasury shares (incl. change in balance)

 

 

8 241

 

1 157

 

9 398

Total comprehensive income for the period

 

 

 

220 948

 

220 948

Balances at March 31, 2021

 

11 080

 

 

3 907 373

 

3 918 453

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balances at January 1, 2022

 

11 080

 

(9 205)

 

3 281 618

 

3 283 493

Dividend

 

 

 

(212 242)

 

(212 242)

Trade with treasury shares (incl. change in balance)

 

 

(10 511)

 

 

(10 511)

Total comprehensive income for the period

 

 

 

(299 861)

 

(299 861)

Balances at March 31, 2022

 

11 080

 

(19 716)

 

2 769 514

 

2 760 878

The notes are an integral part of the condensed consolidated interim financial statements.

BB Biotech AG uses cookies to improve website usability and ensure the best possible user experience. Use of cookies & disclaimer